Literature DB >> 453788

The pathological classification of human mammary carcinoma: past, present and future.

P P Rosen.   

Abstract

The current classification of mammary carcinoma combines pathological and clinical information in order to define prognostically significant categories. Basic structural features are the anatomic unit of origin, either duct or terminal duct-lobule complex, and the presence or absence of invasion. Approximately 90 percent of carcinomas appear to arise from ducts. About one-fifth of invasive duct carcinomas have a better than average prognosis and distinct light microscopic structural patterns. Future study of biochemical markers may permit further refinement of the existing classification of breast carcinoma and lead to the identification of new prognostically significant categories in the heterogeneous group currently referred to as "ordinary" infiltrating duct carcinoma. However, a conservative approach should be adopted toward altering or abandoning the existing classification of breast carcinoma on the basis of immunocytochemical studies until there is an adequate opportunity to determine which, if any, markers are truly clinically relevant.

Entities:  

Mesh:

Year:  1979        PMID: 453788

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  12 in total

Review 1.  Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine.

Authors:  Ashley G Rivenbark; Siobhan M O'Connor; William B Coleman
Journal:  Am J Pathol       Date:  2013-08-27       Impact factor: 4.307

2.  Method for grading breast cancer.

Authors:  E W Elston; I O Ellis
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

3.  Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications.

Authors:  L Pedersen; S Holck; T Schiødt; K Zedeler; H T Mouridsen
Journal:  Breast Cancer Res Treat       Date:  1989-10       Impact factor: 4.872

4.  Predictors of recurrence in stage I (T1N0M0) breast carcinoma.

Authors:  P P Rosen; P E Saigo; D W Braun; E Weathers; A DePalo
Journal:  Ann Surg       Date:  1981-01       Impact factor: 12.969

5.  The clinical behavior of mixed ductal/lobular carcinoma of the breast: a clinicopathologic analysis.

Authors:  Aparna Suryadevara; Lakshmi P Paruchuri; Nassim Banisaeed; Gary Dunnington; Krishna A Rao
Journal:  World J Surg Oncol       Date:  2010-06-21       Impact factor: 2.754

6.  Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections.

Authors:  P P Rosen; M L Lesser; D W Kinne; E J Beattie
Journal:  Ann Surg       Date:  1983-03       Impact factor: 12.969

Review 7.  Tubular carcinoma of the breast. Predicting axillary nodal metastases and recurrence.

Authors:  D J Winchester; A A Sahin; S L Tucker; S E Singletary
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

8.  Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.

Authors:  S R Lakhani; N Collins; M R Stratton; J P Sloane
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

Review 9.  The biology and natural history of breast cancer from the screening perspective.

Authors:  L Holmberg; J Pontén; H O Adami
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

10.  Breast cancer screening: its impact on clinical medicine.

Authors:  H J de Koning; G J van Oortmarssen; B M van Ineveld; P J van der Maas
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.